The aim of this study was to use Pycnogenol® to reduce the recurrence of retinal vein thrombosis (RVT) after a first episode. Pycnogenol® is an anti-inflammatory, anti-edema and an antiplatelet agent with a "mild" antithrombotic activity. The registry, using Pycnogenol® was aimed at reducing the number of repeated episodes of RVT.

Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study

BELCARO, Giovanni;LUZZI, ROBERTA;CORSI, MICHELE;FERAGALLI, Beatrice;GIZZI, CONCETTA;
2015-01-01

Abstract

The aim of this study was to use Pycnogenol® to reduce the recurrence of retinal vein thrombosis (RVT) after a first episode. Pycnogenol® is an anti-inflammatory, anti-edema and an antiplatelet agent with a "mild" antithrombotic activity. The registry, using Pycnogenol® was aimed at reducing the number of repeated episodes of RVT.
2015
Inglese
57
3
121
125
5
Adult; Aspirin; Female; Fibrinolytic Agents; Flavonoids; Humans; Incidence; Italy; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Recurrence; Registries; Retinal Vein Occlusion; Risk Factors; Secondary Prevention; Time Factors; Treatment Outcome
13
info:eu-repo/semantics/article
262
Rodriguez, P; Belcaro, Giovanni; Dugall, M; Hu, S; Luzzi, Roberta; Ledda, A; Ippolito, E; Corsi, Michele; Ricci, A; Feragalli, Beatrice; Cornelli, U; ...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11564/671560
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 9
social impact